Laddar...
BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers
INTRODUCTION: Intrinsic or acquired chemoresistance is a major problem in oncology. Although highly responsive to chemotherapies such as paclitaxel, most triple negative breast cancer (TNBC) patients develop chemoresistance. Here we investigate the role of BRCA1-IRIS as a novel treatment target for...
Sparad:
| I publikationen: | Breast Cancer Res |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4322455/ https://ncbi.nlm.nih.gov/pubmed/25583261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-014-0512-9 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|